DRUG STUDY

Name of Patient: Patient ML Room/[Link]: Medward-2 B-6

Age: 27y/o Physician: DR. O
Gender: M Admitting Diagnosis:
Chief Complaints: Student’s Name and Group_______10_______
Date Name of Drug Picture Classification Dosage/ Indication Mechanism Side Effects Nursing
Time/Ro of Action Responsibilities
ute
Generic Name: Therapeutic Dosage: This The liver CNS: •Educate patient
Calcium + Vit D class: 1 tab product is does the ● Mental/mood on possible side-
Brand Name: Calcium with Time: indicated first changes, effects
Caltrate Plus Vitamins OD for the Hydroxy- Headaches
Pharmacolo Route: prevention lation of •Ensure that the
gical class: Oral and vitamin D3 RT: patient did not
Antianemics treatment Cholecal- Trouble breathing have a
of ciferol, while high-fiber meal
osteoporo the GI: before taking the
sis, kidneys abdominal supplement.
Calcium perform the distension,
and second. abdominal pain, •Advise the
Vitamin D These constipation, patient not to
deficiency vitamin D diarrhea, smoke cigarettes
state metabolites eructation/ or
aid active burping, drink large
calcium and flatulence, amounts of
phosphorus nausea, alcohol or
absorption vomiting, loss of caffeine.
in the small Appetite
intestine, •If the patient
allowing for CS: needs to use
adequate high level of other medicines,
serum calcium in take them at
calcium blood least 2 hours
and (hypercalcaemia) before or 2 hours
phosphate after the patient
levels for GU: takes the
bone excessive loss of calcium
minerali- calcium in urine supplement.
zation. (hypercalciuria)
Conversely, and •Calcium
these kidney stone supplements are
vitamin formation best taken with
D (nephrolithiasis). meals to
metabolites increased ensure optimal
aid in the thirst/urination absorption.
mobilization
of calcium Skin: •Drink a full
and allergic reaction, glass of water (8
phosphate including: rash, ounces) with
from bone itching/swelling each
and dose, unless the
are thought (especially of the patient is on
to enhance face/tongue/ kidney dialysis.
calcium and throat)trouble
possibly breathing. •Do not increase
phosphate or double the
re- Muscular: dose, follow
absorption muscle pain, exactly as
via weakness prescribed. Do
the renal not take a
tubules Skeletal: double
bone pain dose to
compensate for
a forgotten
tablet.

•Document
accordingly

•Monitor for
adverse effects

•Encourage
patient to report
if any reactions
occur: nausea,
vomiting,
 swelling,
difficulty
breathing,
abdominal pain,
diarrhea, rashes.

DRUG STUDY
Name of Patient: Patient ML Room/[Link]: Medward-2 B-6
Age: 27y/o Physician: DR. O
Gender: M Admitting Diagnosis:
Chief Complaints: Student’s Name and Group_______10_______
Date Name of Drug Picture Classification Dosage/ Indication Mechanism Side Effects Nursing
Time/Ro of Action Responsibilities
ute
Generic Name: Therapeutic Dosage: Used for Inhibits CNS: •Obtain a
Nicardipine class: 1mg the calcium ion Headache, complete health
hydrochloride calcium Time: managem influx across dizziness. history including
Brand Name: channel ent of cardiac and [Link] previous MI, HF,
Cardene blockers. Route: patients smooth sthesia. fatigue, muscle
Pharmacolo IV with muscle cells or joint pain.
gical class: chronic but is more CV. Flushing.
stable selective to Palpitation. •Obtain baseline
angina vascular tachycardia, weight, vital
and for smooth peripheral edema, signs, ECG,
the muscle than increased angina. cardiac
treatment cardiac hypotension monitoring &
of muscle. orthostasis breath sounds.
hypertensi Drug also Skin: Rash
on. dilates GI: Nausea, dry • Assess for
coronary mouth desired
arteries and GU: Polyuna therapeutic
arterioles. MS. myalgia, effects.
weakness
Other: • Continue
Diaphoresis periodic
monitoring of
electrolytes
specially
potassium.
 • Assess for
adverse effects
like headache,
dizness,
musculoskeletal
fatigue, nausea,
constipation, etc.

•Document
accordingly

DRUG STUDY
Name of Patient: Patient ML Room/[Link]: Medward-2 B-6
Age: 27y/o Physician: DR. O
Gender: M Admitting Diagnosis:
Chief Complaints: Student’s Name and Group_______10_______
Date Name of Drug Picture Classification Dosage/ Indication Mechanism Side Effects Nursing
Time/Ro of Action Responsibilities
ute
Generic Name: Therapeutic Dosage: Treatment inhibits hypotension, •Assess patient's
Furosemide class: 400mg for sodium and Dehydration, nderlying
Brand Name: Loop Time: edema; chlotide re- electrolyte condition before
Lasix Diuretics PRN Treat absorption depletion (for starting
Route: hypertensi at the example, sodium, theraphy.
Pharmacolo IVTT on proximal potassium)
gical class: and distal jaundice, • Monitor for
tubules and ringing in the ears renal cardiac,
the (tirrutus), neurologic, GI
ascending sensitivity to light manifestations of
loop of (photophobia), hypokalemia
Henle. Rash,
pancreatitis, • Monitor for
Nausea, diarrhea CNS, GI,
abdominal pain cardiovascular,
and dizziness integumentary
Increased blood neurologic
sugar and uric manifestations of
acid level hypocalcemia,

•Monitor for
CNS,
hyperactive
reflexes,
depressed
cardiac output
 nausea,
vomiting,
tachycardia
• Assess fluid
volume
status([Link]
r, quality and
specific gravity)

•Assess patient
tinitus, or pain
•Document
accordingly

DRUG STUDY
Name of Patient: Patient ML Room/[Link]: Medward-2 B-6
Age: 27y/o Physician: DR. O
Gender: M Admitting Diagnosis:
Chief Complaints: Student’s Name and Group_______10_______
Date Name of Drug Picture Classification Dosage/ Indication Mechanism Side Effects Nursing
Time/Ro of Action Responsibilities
ute
Generic Name: Therapeutic Dosage: For the inhibits nausea, •Assess patient
Cefepime class: 1g treatment bacterial for sign and
vomiting,
Hydrochloride Antibiotics Time: of the cell-wall symptoms in fx
Brand Name: Pharmacolo OD following synthesis,pr diarrhea, at
Maxipime gical class: Route: infections omotes beginning/throug
fever,
IV caused by osmotic hout treatment.
susceptibl instability, headache,
e and •Before initiating
itching,
microorga destroys treatment, obtain
nisms: bacteria. rash, and history to
Lower determine
Abnormal blood
respirator tests previous
y tract use/reaction to
infections, penicillins or
including cephalosporins,
pneumoni pt with negative
a history may still
(moderate have a reaction
to severe)
and •Obtain
bronchitis; specimen for
Uncomplic culture/sensitivity
ated and before initiating
complicat treatment
ed urinary
tract •Observe patient
infections for sign of
(UTIs), anaphylaxis.
including Discontinue and
pyeloneph notify HCP.
ritis; Skin
and skin •Keep
structure epinephrine,
infections; antihistamine
Complicat and equipment
ed intra- close by in event
abdominal of anaphylaxis
infections;
including •Monitor bowel
peritonitis function,
and biliary Diarrhea,
tract cramping, fever
infections; and bloody
Empiric
therapy •Document
accordingly
(or febrile
neutropen
ic
patients;
Septicemi
a.
 DRUG STUDY
Name of Patient: Patient ML Room/[Link]: Medward-2 B-6
Age: 27y/o Physician: DR. O
Gender: M Admitting Diagnosis:
Chief Complaints: Student’s Name and Group_______10_______
Date Name of Drug Picture Classification Dosage/ Indication Mechanism Side Effects Nursing
Time/Ro of Action Responsibilities
ute
Generic Name: Therapeutic Dosage: Used as Not clearly •Establish
Prednisone class: 30 mg an anti- defined. baseline and
Brand Name: Corticosteroids Time: inflammat Decrease continuing data
Rayos Pharmacolo BID ory inflammatio regarding BP,
gical class: Route: n, mainly by I&O ratio and
Adrenocor- Oral stabilizing pattern, weight,
ticoids leukocyte fasting blood
lysosomal glucose level,
membranes; and sleep
suppresses pattern.
immune
response; •Start flow chart
stimulates as reference for
bone planning
marrow; and individualized
influences pharmacotherap
protein, fat, eutic patient
and care.
carbohydrat
e •Check and
metabolism record BP during
dose
stabilization
period at least 2
times daily.
Report an
ascending
pattern.

•Monitor patient
for evidence of
HPA axis
suppression
during long-term
therapy by
determining
plasma cortisol
levels at weekly
intervals.

•Lab tests:
Obtain fasting
blood glucose,
serum
electrolytes, and
routine
laboratory
studies at
regular intervals
during long-term
steroid therapy
•Document
accordingly